Victory Capital Management Inc Akouos, Inc. Transaction History

Victory Capital Management Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 02, 2021	SELL	$9.93 - $13.59 $441,189 - $603,803	-44,430 Closed	0 $0
Q2 2021 Aug 03, 2021	SELL	$11.87 - $15.96 $185,480 - $249,390	-15,626 Reduced 26.02%	44,430 $558,000
Q1 2021 May 04, 2021	SELL	$13.87 - $21.04 $30,056 - $45,593	-2,167 Reduced 3.48%	60,056 $833,000
Q4 2020 Feb 01, 2021	SELL	$17.03 - $22.45 $146,543 - $193,182	-8,605 Reduced 12.15%	62,223 $1.23 Million
Q3 2020 Nov 09, 2020	SELL	$19.3 - $26.92 $66,237 - $92,389	-3,432 Reduced 4.62%	70,828 $1.62 Million
Q2 2020 Aug 07, 2020	BUY	$22.0 - $22.5 $1.63 Million - $1.67 Million	74,260 New	74,260 $1.67 Million

Ticker AKUS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,929,000
Description
Akouos, Inc., a precision genetic medicine company, developing gene therapies to restore, improve, and preserve physiologic hearing for individuals. The company's precision genetic medicine platform incorporates a proprietary adeno-associated viral vector library and a novel delivery approach. Its lead product candidate is AK-OTOF, a gene therap...

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Victory Capital Management Inc with notifications on news.